Search Login Register

Alendronate (Alendronate Sodium) Summary

Description: A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

Also Known As: Alendronate Sodium; Fosamax; 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate; Alendronate Monosodium Salt, Trihydrate; Aminohydroxybutane Bisphosphonate Show All >>

Networked: 1891 relevant articles (219 outcomes, 488 trials/studies) for this Drug

Key Diseases for which Alendronate is Relevant

  1. Osteoporosis : 94 outcomes 230 studies in 905 results
  2. Pain (Aches) : 22 outcomes 7 studies in 60 results
  3. Bone Resorption : 20 outcomes 49 studies in 259 results
  4. Postmenopausal Osteoporosis : 19 outcomes 44 studies in 184 results
  5. Metabolic Bone Diseases (Osteopenia) : 17 outcomes 22 studies in 90 results
Show All >>

Drugs Related to Alendronate

  1. risedronic acid (risedronate)
  2. Diphosphonates
  3. Etidronic Acid (HEDP)
  4. Calcium
  5. Vitamin D
  6. Alendronate (Alendronate Sodium)
  7. Raloxifene (Evista)
  8. 1-hydroxycholecalciferol (alfacalcidol)
  9. zoledronic acid (zoledronate)
  10. Teriparatide (Parathar)
Show All >>

Therapies Related to Alendronate

  1. Arthroplasty
  2. Aftercare (After-Treatment)
  3. Hormone Replacement Therapy (Therapy, Hormone Replacement)
  4. Oral Administration
  5. Drug Therapy (Chemotherapy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.